Pangea Natural develops new peptide patch

Executive Summary

• Pangea Natural Foods Inc.'s wholly owned subsidiary, Amino Innovations Inc., has developed a next-generation peptide patch platform utilizing bio-dissolving lattice technology for needle-free, transdermal peptide delivery.
• The technology aims to provide one-to-one equivalence to traditional injectable dosing, offering a painless, shelf-stable (up to six months), and TSA-friendly alternative to injections.
• Initial product launches include two specific formulations: the "Wolverine Stack" patch for recovery and the "TA-1" patch for immune optimization, with further validation and updates expected in Q4 2025.

Key Details

• Technology Platform: Utilizes bio-dissolving lattice technology for rapid and efficient absorption through the skin's surface layers.
• Key Benefits: Needle-free, no pain, no mixing, no reconstitution, no sterile handling required, and no dosing measurement needed.
• Product Specifications: Compact, TSA-friendly, shelf-stable for up to six months, and manufactured in a cGMP-certified facility in the United States.
• Quality Assurance: Each patch undergoes rigorous third-party testing to ensure pharmaceutical-grade purity, stability, and consistency.
• Initial Formulations:
  • Wolverine Stack Patch: Combines BPC-157 and Thymosin Beta 4 (TB4) to support healing, muscle recovery, tissue regeneration, and physical resilience.
  • TA-1 Patch: Formulated to promote immune balance and strengthen the body's natural defense systems.
• Target Audience: Active individuals, travelers, and longevity enthusiasts seeking advanced recovery and wellness support.
• Future Outlook: CEO Pratap Sandhu indicated that further validation via a third-party study could unlock a breakthrough for peptide delivery and expand the total addressable market in North America and globally, with additional updates expected during Q4 2025.

Notable Quotes

• Justin Kirkland, Chief Science Officer and Co-Founder, Amino Innovations: "These new formulations represent a significant step forward in our mission to make advanced peptide science accessible and effortless. We are focused on bringing innovation, integrity and accessibility to a category that is quickly evolving from niche to mainstream. These patches are designed to empower individuals to enhance recovery, cellular health and overall vitality in a simple, convenient and needle-free format."
• Pratap Sandhu, Chief Executive Officer, Pangea Natural Foods: "The development of this patch technology and its further validation via a third-party study could potentially unlock a breakthrough for the delivery of peptides and expand the total addressable market size in North America and globally in a major way. We look forward to providing additional updates during Q4, 2025."